CompletedPhase 4ACTRN12609000996268
Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome
Sponsor
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan
Enrollment
30 participants
Start Date
Jun 1, 2000
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 16 YearssMax Age: 80 Yearss
Inclusion Criteria2
- Biopsy proven idiopathic membranous nephropathy.
- Over 3.5 g/day of excretion of urinary protein.
Exclusion Criteria4
- Secondary forms of membranous nephropathy.
- Less than 70 ml/min of creatinine clearance.
- Patients with relapse or recurrence.
- Treated with other immunosuppressants.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral administration of cyclosporine 3 mg/kg/day and prednisolone 15 mg/day, for a total of 24 months
Oral administration of cyclosporine 3 mg/kg/day and prednisolone 15 mg/day, for a total of 24 months
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000996268